FDA Inspection 1257932 — Colgate-Palmolive China
The FDA completed an inspection of Colgate-Palmolive China on Nov 22, 2024 in Guangzhou. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Drugs.
Inspection Details
- Classification
- No Action Indicated (NAI)
- End Date
- Nov 22, 2024
- Fiscal Year
- 2025
- Product Type
- Drugs
- Project Area
- Drug Quality Assurance
- Location
- Guangzhou (China)